Conceptio
›
multiple-myeloma
Topic
multiple-myeloma
Knowledge-graph topic
· documents ABOUT multiple-myeloma across the archive
675
Documents about multiple-myeloma
Documents about multiple-myeloma
Prevalence, Intensity and Consequences of Bortezomib-induced Neuropathic Disorders.
#828369
ClinicalTrials.gov
Nonmyeloablative Haploidentical Transplant Followed by MLN9708
#845351
ClinicalTrials.gov
Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies
#849903
ClinicalTrials.gov
Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings
#875819
ClinicalTrials.gov
The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19
#896373
ClinicalTrials.gov
Clinical Study of the Safety and Efficacy of BCMA CAR-NK
#909954
ClinicalTrials.gov
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
#852534
ClinicalTrials.gov
Prospective Evaluation of the Prognostic Impact of Measurable Residual Disease (MRD) Within a Phase III Study Comparing a Fixed Duration Therapy Versus Continuous Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma Requiring a First Salvage Treatment.
#865888
ClinicalTrials.gov
Circulating Levels of Insulin-Like Growth Factor I (Igf-I) and Risk Ofmultiple Myeloma: An Observational and Mendelian Randomisation Study
#323901
Scholar Commons
Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
#845610
ClinicalTrials.gov
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
#969728
ClinicalTrials.gov
Socioeconomic Disparities in Multiple Myeloma Survival in New South Wales Australia: A Population-Based Cohort Study.
#146148
NCBI PubMed Central
Environmental exposures and multiple myeloma risk: A contemporary review of epidemiologic associations and mechanistic plausibility.
#242259
NCBI PubMed Central
Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Dostarlimab (GSK4057190) in Participants With RRMM
#287419
ClinicalTrials.gov
Current positioning and future development of belantamab mafodotin and other antibody-drug conjugates to treat multiple myeloma
#320318
IRIS
Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myeloma.
#320537
NCBI PubMed Central
Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM
#321588
ClinicalTrials.gov
Bortezomib Induces Apoptosis via Upregulation of Abhd4 in Peripheral Nerve Cells
#323302
OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies
#411402
ClinicalTrials.gov
Smoldering multiple myeloma: a multi-country mixed-methods study on disease perceptions and patient treatment preferences.
#645133
NCBI PubMed Central
Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant
#841806
ClinicalTrials.gov
Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Clinical Activity of GSK2857916
#849397
ClinicalTrials.gov
A Study to Evaluate the Subcutaneous Belantamab (BCMAb) Formulation Versus Intravenous Belantamab in Participants With Multiple Myeloma While Treated With Standard of Care
#884059
ClinicalTrials.gov
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
#840930
ClinicalTrials.gov
A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma
#851534
ClinicalTrials.gov
An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies
#870811
ClinicalTrials.gov
Risk of synchronous and second primary malignancies in transplant-ineligible patients with multiple myeloma treated with lenalidomide
#195831
HAL (France)
Lesion-level dual-tracer PET biomarkers predict prognosis in multiple myeloma treated with CXCR4-directed radiopharmaceutical therapy.
#222958
NCBI PubMed Central
Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant
#332758
ClinicalTrials.gov
A Simulation-Based Assessment of Dosage Regimen Appropriateness for Multiple Myeloma Medicines Reflecting Demographic and Ethnic Differences.
#412377
NCBI PubMed Central
From static risk to dynamic disease monitoring: the role of MRD and immune profiling in multiple myeloma.
#653411
NCBI PubMed Central
Phase II Study of Lenalidomide/Dexamethasone With or Without Elotuzumab for Newly Diagnosed MM Patients in Japan
#825359
ClinicalTrials.gov
Umbilical Cord Blood Transplant for Hematological Malignancies
#826192
ClinicalTrials.gov
Emapalumab Prophylaxis of Bispecific T-Cell Engagers (BiTEs) Associated CRS and ICANS
#878514
ClinicalTrials.gov
Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation
#883661
ClinicalTrials.gov
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration
#887076
ClinicalTrials.gov
The Effect of Self Acupressure Application on Pain, Fatigue and Sleep Quality in Multiple Myeloma Patients
#900848
ClinicalTrials.gov
D2 - Isa-Iber-VD Induction, Followed by Risk & Response Adapted Consolidation & Maintenance, in Transplant-Eligible NDMM
#902099
ClinicalTrials.gov
A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation
#892029
ClinicalTrials.gov
Supportive care for talquetamab-related dysgeusia in multiple myeloma: mixed-methods evidence, nutrition-focused flowchart, and digital companion concept.
#295072
NCBI PubMed Central
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
#442106
ClinicalTrials.gov
A Circulating TLR2pos CD14neg CD16neg '' Unclassified Subset '' is Decreased in Multiple Myeloma Patients and May Comprise CD163pos Dendritic Cells.
#480158
bioRxiv / medRxiv
The Genetic and Molecular Drivers of Multiple Myeloma: Current Insights, Clinical Implications, and the Path Forward.
#684040
eScholarship
Optimal, off-the-shelf, CAR-iNKT cell platform-based immunotherapy for multiple myeloma
#781873
Spiral
cGA in Newly-diagnosed Elderly MM Patients: a Multi-center, Prospective, Non-interventional Study.
#843538
ClinicalTrials.gov
Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
#856369
ClinicalTrials.gov
Subcutaneous (SC) Bortezomib-Regimens for Patients With RR MM Failing Prior IV Bortezomib-Containing Regimens
#857797
ClinicalTrials.gov
Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma
#865038
ClinicalTrials.gov
Bortezomib in Combination With Liposomal Doxorubicin and Dexamethasone to Treat Plasma Cell Leukemia
#871498
ClinicalTrials.gov
HD Melphalan and SCT in Patients With IGDD or LCDD
#880563
ClinicalTrials.gov
← Previous
Page 16 of 20
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.